Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?

References

• Halling ML, Kjeldsen J, Knudsen T, et al. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23:6137–6146.
   PubMed Web of Science ®Google Scholar
• Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42:97–114.
   PubMed Web of Science ®Google Scholar
• Greuter T, Navarini A, Vavricka SR. Skin manifestations of inflammatory bowel disease. Clin Rev Allergy Immunol. 2017;53:413–427.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Borghi A, Stadnicki A, et al. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features and therapy. Infl Bowel Dis. 2014;20:213–227.
   PubMed Web of Science ®Google Scholar
• Kim M, Choi KH, Hwang SW, et al. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population-based cross-sectional study. J Am Acad Dermatol. 2017;76:40–48.
   PubMed Web of Science ®Google Scholar
• Richter L, Rappersberger K. Cutaneous involvement in chronic inflammatory bowel disease: Crohn’s d13. J Gastroenterol Hepatol. 2014;29:291–295.
   PubMedGoogle Scholar
• Trost LB, Mc Donnel JK. Important cutaneous manifestations of inflammatory bowel diseases. Postgrad Med J. 2005;81:580–585.
   PubMed Web of Science ®Google Scholar
• Vide J, Osorio F, Costa-Silva M, et al. Cutaneous morbidity among inflammatory bowel disease patients: a cohort study. J Crohn’s Colitis. 2018;18:1–10.
   Google Scholar
• Cipriani F, Marzatico A, Ricci G. Autoimmune diseases involving skin and intestinal mucosa are more frequent in adolescents and young adult suffering from atopic dermatitis. J Dermatol. 2017;44:1341–1348.
   PubMed Web of Science ®Google Scholar
• Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008;87:281–293.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.
   PubMed Web of Science ®Google Scholar
• Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131:33–45.
   PubMed Web of Science ®Google Scholar
• Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745–757.
   PubMed Web of Science ®Google Scholar
• Yan F, Cao H, Cover TL, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011;121:2242–2253.
   PubMed Web of Science ®Google Scholar
• Qiao YQ, Cai CW, Ran ZH. Therapeutic modulation of gut microbiota in inflammatory bowel disease: more questions to be answered. J Dig Dis. 2016;17:800–810.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Antibiotics, probiotics and prebiotics in IBD. Nestle Nutr Inst Workshop Ser. 2014;79:83–100.
   PubMedGoogle Scholar
• Jewell D. Do. HLA antigens predict the occurrence of extraintestinal manifestations of IBD? Inflamm Bowel Dis. 2008;14:S28.
   PubMed Web of Science ®Google Scholar
• Cleynen I, González JR, Figueroa C, et al. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBD chip. Eur Project Gut. 2013;62:1556–1565.
   PubMed Web of Science ®Google Scholar
• Vavricka SR, Rogler G, Gantenbein C, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21:1794–1800.
   PubMed Web of Science ®Google Scholar
• Veloso FT, Ferreira JT, Barros L, et al. Enviromental and genetic factors have been implicated in the pathogenesis of IBD and cIEM. Inflamm Bowel Dis. 2001;7:306–313.
   PubMed Web of Science ®Google Scholar
• Ciccacci C, Biancone L, Di Fusco D, et al. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2013;7:44–52.
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Kobayashi T, Ueno F, et al. Evidence based clinical practice guidelines for imflammatory bowel disease. J Gastroenterol. 2018;53:305–353.
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53:1617–1623.
   PubMed Web of Science ®Google Scholar
• Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354:635–639.
   PubMed Web of Science ®Google Scholar
• Guslandi M, Mezzi G, Sorghi M, et al. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci. 2000;45:1462–1464.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309.
   PubMed Web of Science ®Google Scholar
• Zippi M, Corrado C, Pica R, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20:17463–17467.
   PubMed Web of Science ®Google Scholar
• Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–2307.
   PubMed Web of Science ®Google Scholar
• Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. ECCOJC. 2016;10:429–436.
   Web of Science ®Google Scholar